One-Two punch: new procedure aims to free kidney patients from lifelong drugs
NCT ID NCT05900401
Summary
This study is testing a new approach for people who have received a kidney transplant. After the kidney transplant, patients get a bone marrow transplant from the same donor. The goal is to 're-educate' the patient's immune system to accept the new kidney, potentially allowing them to safely stop taking powerful anti-rejection medications for good. The trial will check if this combined transplant is safe and if it successfully creates long-term tolerance to the donated kidney.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.